Janux Therapeutics, Inc. (JANX)

NASDAQ

$15.13

-$0.17 (1.11%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$14.85$15.58

Open $15.41

52 Week Range

$14.85$63.00

Previous Close $15.30

Market Cap910.02M

Volume1.99M

Avg Volume1.49M

P/E (TTM)-9.30

EPS (TTM)$-1.64

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for Janux Therapeutics, Inc.

DEC12025

Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC

Source: Business Wire•14 days ago

SAN DIEGO--(BUSINESS WIRE)---- $JANX--Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC....

NOV242025

Janux Therapeutics to Host Virtual Event Discussing Updated Phase 1a and Phase 1b Clinical Data for JANX007 in mCRPC

Source: Business Wire•21 days ago

SAN DIEGO--(BUSINESS WIRE)---- $JANX--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor Activated T C...

NOV62025

Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights

Source: Business Wire•39 days ago